In the Orphan Drug Approval Race, Winner Takes All? Ramifications of Catalyst Pharms. v. Becerra

October 11, 2021

Ownership of Inventions By Former Employers: Lessons after Bio-Rad v. ITC

September 9, 2021

Ownership of Inventions By Former Employers: Lessons after Bio-Rad v. ITC

September 9, 2021

“Advancing Education on Biosimilars”: Game Changer or More of the Same?

May 26, 2021

Generic Competition for Withdrawn Drug Products

March 25, 2021

Generic Competition for Withdrawn Drug Products

March 25, 2021

I’ve Been Sued for Patent Infringement… Is an IPR Worthwhile?

February 4, 2021

I’ve Been Sued for Patent Infringement… Is an IPR Worthwhile?

February 4, 2021

H.R. 4712: A “Narrowly Tailored” Obligation Under the Orphan Drug Act

November 20, 2020

Pre-Election Drug Pricing Regulation Efforts: Where Does Congress Stand?

September 30, 2020